OrbiMed Israel GP Ltd. - Jun 23, 2021 Form 4 Insider Report for 9 METERS BIOPHARMA, INC. (NMTR)

Role
10%+ Owner
Signature
OrbiMed Israel GP Ltd., By: /s/ Douglas Coon, Chief Compliance Officer
Stock symbol
NMTR
Transactions as of
Jun 23, 2021
Transactions value $
-$20,932,966
Form type
4
Date filed
6/25/2021, 07:08 PM
Previous filing
May 13, 2021
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMTR Common Stock Sale -$1.14M -842K -3.27% $1.36* 24.9M Jun 23, 2021 See Footnotes F1, F3
transaction NMTR Common Stock Sale -$441K -319K -1.28% $1.38* 24.6M Jun 24, 2021 See Footnotes F1, F3
transaction NMTR Common Stock Sale -$19.3M -16M -65.12% $1.21* 8.57M Jun 25, 2021 See Footnotes F1, F3
holding NMTR Common Stock 31.9K Jun 23, 2021 See Footnotes F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's common stock are held of record by OrbiMed Israel Partners Limited Partnership ("OIP"). OrbiMed Israel BioFund GP Limited Partnership ("OrbiMed BioFund") is the general partner of OIP, and OrbiMed Israel GP Ltd. ("OrbiMed Israel GP") is the general partner of OrbiMed BioFund.
F2 These shares of the Issuer's common stock are held of record by Nissim Darvish ("Darvish"). Pursuant to an agreement with OrbiMed BioFund and OrbiMed Israel GP, Darvish is obligated to transfer these securities, or the economic benefit thereof, to OrbiMed BioFund and OrbiMed Israel GP, which will in turn ensure that such securities or economic benefits are provided to OIP.
F3 This report is being jointly filed by OrbiMed BioFund and OrbiMed Israel GP. Each of the Reporting Persons and Darvish disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such person or entity, including the Reporting Persons, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.